Targeting MET in Lung Cancer: Will Expectations Finally Be MET?
Top Cited Papers
Open Access
- 26 October 2016
- journal article
- review article
- Published by Elsevier BV in Journal of Thoracic Oncology
- Vol. 12 (1), 15-26
- https://doi.org/10.1016/j.jtho.2016.10.014
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- ALK in Lung Cancer: Past, Present, and FutureJournal of Clinical Oncology, 2013
- An overview of the c-MET signaling pathwayTherapeutic Advances in Medical Oncology, 2011
- Co-Activation of Epidermal Growth Factor Receptor and c-MET Defines a Distinct Subset of Lung AdenocarcinomasThe American Journal of Pathology, 2010
- Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLCCancer Cell, 2010
- Ethnic Differences and Functional Analysis of MET Mutations in Lung CancerClinical Cancer Research, 2009
- Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer PatientsJournal of Clinical Oncology, 2009
- Met gene copy number predicts the prognosis for completely resected non‐small cell lung cancerCancer Science, 2008
- Expression and mutational analysis of MET in human solid cancersGenes, Chromosomes and Cancer, 2008
- MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 SignalingScience, 2007
- Expression of c‐met/HGF Receptor in Human Non‐small Cell Lung Carcinomas in vitro and in vivo and Its Prognostic SignificanceJapanese Journal of Cancer Research, 1996